Shigellosis -- United States
This Health Advisory describes the identification of emerging _Shigella_ strains with elevated minimum inhibitory concentration values for ciprofloxacin and outlines new recommendations for clinical diagnosis, management, and reporting, as well as new recommendations for laboratories and public health officials. Current interpretive criteria provided by the Clinical and Laboratory Standards Institute (CLSI) categorize these strains as susceptible to ciprofloxacin, which is a fluoroquinolone
Read more about it at HealthMap Global Disease Alerts via http://bit.ly/2owmglf
No comments:
Post a Comment